Today, the Cystic Fibrosis Foundation announced an additional investment of up to $24 million in Prime Medicine to continue ...

The CF Foundation supports a wide range of innovative research programs to discover and develop new and effective CF therapies.

The Northern California Chapter of the Cystic Fibrosis Foundation welcomes you! Volunteers are the key to our success and the lifeblood of our organization. We have many opportunities for you to get ...

The Central Ohio Chapter of the Cystic Fibrosis Foundation welcomes you! Our chapter covers Columbus, Cincinnati, Dayton and the surrounding areas. Volunteers are the key to our success and the ...

The Connecticut Chapter of the Cystic Fibrosis Foundation welcomes you! Volunteers are the key to our success and the lifeblood of our organization. We have many opportunities for you to get involved.

The Rocky Mountain Chapter of the Cystic Fibrosis Foundation welcomes you! Volunteers are the key to our success and the lifeblood of our organization. We have many opportunities for you to get ...

The Greater Illinois Chapter of the Cystic Fibrosis Foundation welcomes you! Our chapter covers Chicago, Peoria, NW Indiana and the surrounding areas. Volunteers are the key to our success and the ...

The CF Foundation has been closely monitoring the COVID-19 pandemic and how it may affect people with cystic fibrosis and their families. Resources are available to help inform and provide a sense of ...

The Maryland Chapter of the Cystic Fibrosis Foundation welcomes you! Volunteers are the key to our success and the lifeblood of our organization. We have many opportunities for you to get involved.

Mucus thinners, such as mucolytics, are inhaled medications that help thin the mucus in the airways so you can cough it out of your lungs more easily.

Because cystic fibrosis is a complex disease, it requires a team approach with you or your child at the center. Your CF care team includes a group of CF health care professionals who partner with you ...

Cystic fibrosis is caused by mutations in both copies of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Scientists are examining whether it is possible to correct the mutations ...